S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

$0.41
-0.02 (-4.65%)
(As of 03/28/2024 ET)
Today's Range
$0.41
$0.45
50-Day Range
$0.37
$0.68
52-Week Range
$0.37
$1.86
Volume
50,495 shs
Average Volume
173,750 shs
Market Capitalization
$6.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50

Applied DNA Sciences MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
265.9% Upside
$1.50 Price Target
Short Interest
Healthy
1.54% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of Applied DNA Sciences in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.63) to ($0.48) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.74 out of 5 stars

APDN stock logo

About Applied DNA Sciences Stock (NASDAQ:APDN)

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

APDN Stock Price History

APDN Stock News Headlines

Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
Applied DNA Sciences Inc.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Q1 2024 Applied DNA Sciences Inc Earnings Call
Recap: Applied DNA Sciences Q1 Earnings
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Earnings Preview For Applied DNA Sciences
Applied DNA Sciences Inc (APDN)
See More Headlines
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
3/29/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Testing laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:APDN
Employees
52
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.50
High Stock Price Target
$1.50
Low Stock Price Target
$1.50
Potential Upside/Downside
+265.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,950,000.00
Pretax Margin
-81.25%

Debt

Sales & Book Value

Annual Sales
$13.37 million
Book Value
$0.36 per share

Miscellaneous

Free Float
15,239,000
Market Cap
$6.96 million
Optionable
Optionable
Beta
0.11
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. James A. Hayward Ph.D. (Age 70)
    Sc.D., Chairman, President & CEO
    Comp: $468k
  • Ms. Beth M. Jantzen CPA (Age 48)
    Chief Financial Officer
    Comp: $300k
  • Ms. Judith Murrah (Age 66)
    COO, Chief Information Officer & Secretary
    Comp: $325k
  • Mr. Clay Shorrock Esq. (Age 39)
    J.D., Chief Legal Officer & Executive Director of Business Development
    Comp: $300k
  • Mr. Sanjay M. Hurry
    Executive Director of Investor Relations & Corporate Communications
  • Mr. Tony Benson
    Managing Director of EMEA
  • Mr. Joseph L. Magno
    Sales Consultant
  • Mr. Warren Pearlson
    Sales Consultant

APDN Stock Analysis - Frequently Asked Questions

Should I buy or sell Applied DNA Sciences stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" APDN shares.
View APDN analyst ratings
or view top-rated stocks.

What is Applied DNA Sciences' stock price target for 2024?

1 Wall Street research analysts have issued 12-month target prices for Applied DNA Sciences' shares. Their APDN share price targets range from $1.50 to $1.50. On average, they anticipate the company's stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 265.9% from the stock's current price.
View analysts price targets for APDN
or view top-rated stocks among Wall Street analysts.

How have APDN shares performed in 2024?

Applied DNA Sciences' stock was trading at $0.6168 at the beginning of 2024. Since then, APDN shares have decreased by 33.5% and is now trading at $0.41.
View the best growth stocks for 2024 here
.

When is Applied DNA Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our APDN earnings forecast
.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) announced its earnings results on Thursday, February, 8th. The technology company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.31) by $0.22. The technology company earned $0.89 million during the quarter, compared to the consensus estimate of $0.70 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 159.93% and a negative net margin of 80.14%.

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by many different retail and institutional investors. Top institutional investors include AMH Equity Ltd (2.69%), Silverberg Bernstein Capital Management LLC (0.72%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Applied DNA Sciences?

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:APDN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners